Histopathologic and Antioxidant Regulatory Effects of Different Doses of Thymoquinone Against 2,4,6‐Trinitrobenzene Sulfonic Acid‐Induced Experimental Colitis in Rats
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Ferhat Sirinyıldız und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Turkey. Hauptthemen laut MEDLINE: Benzoquinones, Trinitrobenzenesulfonic Acid, Antioxidants, Colitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
The aim of this study was to investigate the potential role of thymoquinone in the treatment of inflammatory bowel disease (IBD) by examining the effects of various doses of thymoquinone on histopathological changes, oxidative stress, and antioxidant markers in basic stamens in a 2,4,6‐trinitrobenzene sulfonic acid (TNBS)‐induced colitis model in rats. Thirty‐two rats were divided into four groups: control, TNBS, thymoquinone‐20 (20 mg/kg), and thymoquinone‐50 (50 mg/kg) groups. The basic stamens of 32 rats were used for this experiment. Malondialdehyde, myeloperoxidase, and superoxide dismutase (inhibition rate) levels and histopathological scores (cellular infiltration, tissue integrity disruption, hemorrhagic focus, and mucosal loss) increased in the rats with TNBS, while they decreased with different thymoquinone doses. Glutathione peroxidase levels were decreased in the rats with TNBS, whereas increased with different thymoquinone doses. Furthermore, catalase levels were decreased in the rats with TNBS and increased with a 50 mg/kg thymoquinone dose. Malondialdehyde, catalase, myeloperoxidase, and superoxide dismutase (inhibition rate) levels and cell infiltration, tissue integrity disruption, and hemorrhagic focus scores detected in the thymoquinone‐50 group were not different from the healthy control group. In conclusion, thymoquinone may be considered as a potential therapeutic agent in the treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Turkey.
- Department of Biophysics, Faculty of Medicine, Usak University, Usak, Turkey.
- Department of Biochemistry (Medicine), Institute of Health Sciences, Aydın Adnan Menderes University, Aydin, Turkey.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sirinyıldız, F., Unay, S., & Keskin, A. (2025). Histopathologic and Antioxidant Regulatory Effects of Different Doses of Thymoquinone Against 2,4,6‐Trinitrobenzene Sulfonic Acid‐Induced Experimental Colitis in Rats. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70110
Vancouver
Sirinyıldız F, Unay S, Keskin A. Histopathologic and Antioxidant Regulatory Effects of Different Doses of Thymoquinone Against 2,4,6‐Trinitrobenzene Sulfonic Acid‐Induced Experimental Colitis in Rats. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70110
BibTeX
@article{Sirinyldz2025,
author = {Sirinyıldız, Ferhat and Unay, Simge and Keskin, Adem},
title = {Histopathologic and Antioxidant Regulatory Effects of Different Doses of Thymoquinone Against 2,4,6‐Trinitrobenzene Sulfonic Acid‐Induced Experimental Colitis in Rats},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70110}
}
EUVIMED